Literature DB >> 29954935

Acute myeloid leukemia in very old patients.

Vladimir Lj Lazarevic1, Anders Bredberg2, Fryderyk Lorenz3, Emma Öhlander4, Petar Antunovic5, Jörg Cammenga6, Lovisa Wennström7, Lars Möllgård7, Stefan Deneberg8, Åsa Derolf8, Martin Höglund9, Gunnar Juliusson10,11.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29954935      PMCID： PMC6269311          DOI： 10.3324/haematol.2018.196691

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation.

Authors:  Mohamed L Sorror; Rainer F Storb; Brenda M Sandmaier; Richard T Maziarz; Michael A Pulsipher; Michael B Maris; Smita Bhatia; Fabiana Ostronoff; H Joachim Deeg; Karen L Syrjala; Elihu Estey; David G Maloney; Frederick R Appelbaum; Paul J Martin; Barry E Storer
Journal:  J Clin Oncol       Date:  2014-08-25       Impact factor: 44.544

Review 2.  Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review.

Authors:  Shantell C Nolen; Marcella A Evans; Avital Fischer; Maria M Corrada; Claudia H Kawas; Daniela A Bota
Journal:  Mech Ageing Dev       Date:  2017-05-11       Impact factor: 5.432

Review 3.  Frailty and the management of hematologic malignancies.

Authors:  Gregory A Abel; Heidi D Klepin
Journal:  Blood       Date:  2017-11-15       Impact factor: 22.113

4.  Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Jenny N Poynter; Michaela Richardson; Cindy K Blair; Michelle A Roesler; Betsy A Hirsch; Phuong Nguyen; Adina Cioc; Erica Warlick; James R Cerhan; Julie A Ross
Journal:  Cancer Epidemiol       Date:  2015-12-22       Impact factor: 2.984

5.  Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: a report from the Swedish Acute Leukemia Registry.

Authors:  Erik Hulegårdh; Christer Nilsson; Vladimir Lazarevic; Hege Garelius; Petar Antunovic; Åsa Rangert Derolf; Lars Möllgård; Bertil Uggla; Lovisa Wennström; Anders Wahlin; Martin Höglund; Gunnar Juliusson; Dick Stockelberg; Sören Lehmann
Journal:  Am J Hematol       Date:  2015-01-16       Impact factor: 10.047

Review 6.  Cancer prevalence and mortality in centenarians: a systematic review.

Authors:  Nicholas Pavlidis; Giorgio Stanta; Riccardo A Audisio
Journal:  Crit Rev Oncol Hematol       Date:  2011-10-22       Impact factor: 6.312

Review 7.  Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.

Authors:  Bas J Wouters; Ruud Delwel
Journal:  Blood       Date:  2015-12-10       Impact factor: 22.113

Review 8.  Emerging therapeutic drugs for AML.

Authors:  Eytan M Stein; Martin S Tallman
Journal:  Blood       Date:  2015-12-10       Impact factor: 22.113

9.  Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Authors:  Gunnar Juliusson; Petar Antunovic; Asa Derolf; Sören Lehmann; Lars Möllgård; Dick Stockelberg; Ulf Tidefelt; Anders Wahlin; Martin Höglund
Journal:  Blood       Date:  2008-11-13       Impact factor: 22.113

10.  Prevalence and characteristics of survivors from acute myeloid leukemia in Sweden.

Authors:  G Juliusson; J Abrahamsson; V Lazarevic; P Antunovic; Å Derolf; H Garelius; S Lehmann; K Myhr-Eriksson; L Möllgård; B Uggla; A Wahlin; L Wennström; M Höglund
Journal:  Leukemia       Date:  2016-10-31       Impact factor: 11.528
View more
  6 in total

1.  Treatment patterns and outcomes of octogenarian patients with acute myeloid leukemia.

Authors:  Vijaya R Bhatt; Valerie Shostrom; James O Armitage; Krishna Gundabolu
Journal:  Am J Hematol       Date:  2019-04-01       Impact factor: 10.047

2.  Characteristics and Outcomes of Adult Patients in the PETHEMA Registry with Relapsed or Refractory FLT3-ITD Mutation-Positive Acute Myeloid Leukemia.

Authors:  David Martínez-Cuadrón; Josefina Serrano; José Mariz; Cristina Gil; Mar Tormo; Pilar Martínez-Sánchez; Eduardo Rodríguez-Arbolí; Raimundo García-Boyero; Carlos Rodríguez-Medina; Carmen Martínez-Chamorro; Marta Polo; Juan Bergua; Eliana Aguiar; María L Amigo; Pilar Herrera; Juan M Alonso-Domínguez; Teresa Bernal; Ana Espadana; María J Sayas; Lorenzo Algarra; María B Vidriales; Graça Vasconcelos; Susana Vives; Manuel M Pérez-Encinas; Aurelio López; Víctor Noriega; María García-Fortes; María C Chillón; Juan I Rodríguez-Gutiérrez; María J Calasanz; Jorge Labrador; Juan A López; Blanca Boluda; Rebeca Rodríguez-Veiga; Joaquín Martínez-López; Eva Barragán; Miguel A Sanz; Pau Montesinos
Journal:  Cancers (Basel)       Date:  2022-06-06       Impact factor: 6.575

3.  AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report.

Authors:  Era L Pogosova-Agadjanyan; Anna Moseley; Megan Othus; Frederick R Appelbaum; Thomas R Chauncey; I-Ming L Chen; Harry P Erba; John E Godwin; Isaac C Jenkins; Min Fang; Mike Huynh; Kenneth J Kopecky; Alan F List; Jasmine Naru; Jerald P Radich; Emily Stevens; Brooke E Willborg; Cheryl L Willman; Brent L Wood; Qing Zhang; Soheil Meshinchi; Derek L Stirewalt
Journal:  Biomark Res       Date:  2020-08-12

Review 4.  Determination of fitness and therapeutic options in older patients with acute myeloid leukemia.

Authors:  Jorge E Cortes; Priyanka Mehta
Journal:  Am J Hematol       Date:  2021-01-12       Impact factor: 10.047

5.  miR-143-3p represses leukemia cell proliferation by inhibiting KAT6A expression.

Authors:  Dan Xu; Jinlong Jiang; Guangsheng He; Haixia Zhou; Chengfu Ji
Journal:  Anticancer Drugs       Date:  2022-01-01       Impact factor: 2.248

6.  Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?

Authors:  David Martínez-Cuadrón; Josefina Serrano; Cristina Gil; Mar Tormo; Pilar Martínez-Sánchez; José A Pérez-Simón; Raimundo García-Boyero; Carlos Rodríguez-Medina; María López-Pavía; Celina Benavente; Juan Bergua; Esperanza Lavilla-Rubira; María L Amigo; Pilar Herrera; Juan M Alonso-Domínguez; Teresa Bernal; Mercedes Colorado; María J Sayas; Lorenzo Algarra; María B Vidriales; Gabriela Rodríguez-Macías; Susana Vives; Manuel M Pérez-Encinas; Aurelio López; Víctor Noriega; María García-Fortes; Fernando Ramos; Juan I Rodríguez-Gutiérrez; Lisette Costilla-Barriga; Jorge Labrador; Blanca Boluda; Rebeca Rodríguez-Veiga; Joaquín Martínez-López; Miguel A Sanz; Pau Montesinos
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.